Clorox (NYSE: CLX) is expected to report Q1 earnings around Oct. 31. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Clorox's revenues will grow 3.6% and EPS will shrink -2.0%.

The average estimate for revenue is $1.35 billion. On the bottom line, the average EPS estimate is $0.96.

Revenue details
Last quarter, Clorox recorded revenue of $1.54 billion. GAAP reported sales were 4.0% higher than the prior-year quarter's $1.48 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, EPS came in at $1.32. GAAP EPS of $1.32 for Q4 were 4.8% higher than the prior-year quarter's $1.26 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 42.7%, 80 basis points worse than the prior-year quarter. Operating margin was 18.7%, 30 basis points worse than the prior-year quarter. Net margin was 11.3%, 10 basis points worse than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $5.65 billion. The average EPS estimate is $4.30.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 833 members out of 869 rating the stock outperform, and 36 members rating it underperform. Among 278 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 273 give Clorox a green thumbs-up, and five give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Clorox is hold, with an average price target of $70.38.

Can your portfolio provide you with enough income to last through retirement? You'll need more than Clorox. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.

Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool owns shares of The Clorox Company. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.